NCT06752876 CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy, in Patients With Refractory Systemic Lupus Erythematosus (GALLOP) Status WITHDRAWN Phase PHASE1
NCT06717815 Phase IIa Study for IPG11406 in Patients With Lupus Nephritis Status RECRUITING Phase PHASE1/PHASE2
NCT06711887 Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension) Status RECRUITING Phase PHASE3
NCT06681337 Universal CAR-T Cell Therapy for Refractory Lupus Nephritis Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT06631404 Renal Arterial Resistive Index as a Noninvasive Biomarker of Disease Activity in Lupus Nephritis Patients Status RECRUITING Phase N/A
NCT06610422 Association Between Neuropathy and Some Autoantibodies in Systemic Lupus Erythematosus (SLE) Patients Status NOT_YET_RECRUITING Phase N/A
NCT06581198 A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN) Status RECRUITING Phase PHASE2
NCT06557265 A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1) Status RECRUITING Phase PHASE1/PHASE2
NCT06544330 A Phase 1 Study of SYNCAR-001 + STK-009 Without Conditioning Chemotherapy (Lymphodepletion) in Subjects With Severe, Refractory Systemic Autoimmune Rheumatic Disease Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06527872 Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN Status RECRUITING Phase N/A
NCT06497387 Safety and Efficacy of PRG-1801 for Refractory Lupus Nephritis and IgG4-Related Disease Status RECRUITING Phase EARLY_PHASE1
NCT06497361 Safety and Efficacy of PRG-2311 for Refractory Lupus Nephritis and IgG4-Related Disease Status RECRUITING Phase EARLY_PHASE1
NCT06491602 A Study of Clinical Characteristics ,Risk Factors and Outcome of Lupus Nephritis Among Children With Systemic Lupus Erthromatousus in Sohag Univeristy Hospital Status RECRUITING Phase N/A
NCT06485648 Mesenchymal Stem Cell Transfusion for the Treatment of Refractory Lupus Nephritis Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT06434363 Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders Status RECRUITING Phase PHASE1/PHASE2
NCT06429800 A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Systemic Lupus Erythematosus Status WITHDRAWN Phase PHASE1